#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent Amyotrophic lateral sclerosis gene carrier Thrombotic thrombocytopenic purpura Clear cell papillary renal cell carcinoma B-cell lymphoma refractory VEXAS syndrome Paroxysmal nocturnal haemoglobinuria Acute on chronic liver failure Spinal muscular atrophy Marginal zone lymphoma refractory Palmar-plantar erythrodysaesthesia syndrome Salivary gland cancer Thalassaemia alpha Prostate cancer Mucopolysaccharidosis III More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Life with Disease Kearns-Sayre syndrome – Trials in Disease Uterine leiomyosarcoma – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics Mastocytosis – Diagnostics Pulmonary fibrosis – Basic Information Congenital hypotransferrinaemia – Treatment Anaplastic thyroid cancer – Life with Disease Tuberous sclerosis complex – Life with Disease Loeys-Dietz syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk4527226 Ropivacaine Mk-1167 Darbepoetin Alfa Zagociguat T89 Etrasimod Arginine Tretinoin Tiratricol Fosaprepitant Mannitol Pamidronate Disodium Glasdegib Ascorbic Acid Fexofenadine Hydrochloride Ro7589655 11902A Ivermectin Melphalan Hydrochloride Mk-6194 More therapies…

    Learn about Your Condition

    Papilloma viral infection Klinefelter's syndrome Adenomyosis Cartilage injury Aplasia pure red cell Friedreich's ataxia Inner ear disorder Radicular pain HER2 positive breast cancer Hypoparathyroidism Aortic stenosis Bile duct adenocarcinoma Foetal growth restriction Breast angiosarcoma metastatic Carotid artery occlusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pneumologie, Allergologie Praxis Dr. Thomas Ginko

Pneumologie, Allergologie Praxis Dr. Thomas Ginko

Vorgebirgsstraße 43, Bonn, 53119, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Testing sublingual immunotherapy with dermatophagoides pteronyssinus extract for adults with moderate to severe house dust mite allergy

    Not recruiting

    4 1
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus Extract
    Germany Spain

  • Study of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose

    Not recruiting

    4 1
    Investigated Diseases:
    • Seasonal allergy
    • Conjunctivitis allergic
    Investigated Drugs:
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Germany

  • Study of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis

    Not recruiting

    4 1
    Investigated Diseases:
    • Seasonal allergy
    • Conjunctivitis allergic
    Investigated Drugs:
    • Phleum Pratense Pollen Extract
    Germany

  • Study of sublingual birch pollen extract (SLI-RX-BET) in different doses for patients with moderate to severe allergic rhinitis caused by birch pollen

    Not recruiting

    4 1
    Investigated Diseases:
    • Seasonal allergy
    • Conjunctivitis allergic
    Investigated Drugs:
    • Betula Pollen Extract
    Germany

  • Study of CLU-RX-BET injection therapy for patients with moderate to severe birch pollen allergies

    Not recruiting

    4 1
    Germany

  • Study on the Effectiveness and Safety of CLU-RX-DPT for Patients with Moderate-to-Severe House Dust Mite Allergy

    Not recruiting

    4 1
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Germany Spain

  • Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    Investigated Drugs:
    • Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
    Germany Poland

  • Study on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Mepolizumab
    Belgium France Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Alternaria Alternata (402)
    • Alternaria Alternata Extract
    • Ambrosia Artemisiifolia (302)
    Germany

  • Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tanimilast
    Bulgaria Czechia Germany Hungary Italy Latvia +4
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!